Roberto Piciotti

484 total citations
15 papers, 317 citations indexed

About

Roberto Piciotti is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roberto Piciotti has authored 15 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roberto Piciotti's work include Liver Disease Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers) and Muscle Physiology and Disorders (2 papers). Roberto Piciotti is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers) and Muscle Physiology and Disorders (2 papers). Roberto Piciotti collaborates with scholars based in Italy, Belgium and United Kingdom. Roberto Piciotti's co-authors include Elham Sajjadi, Nicola Fusco, Konstantinos Venetis, Marco Invernizzi, Carmen Criscitiello, Stefania Morganti, Marica Meroni, Paola Dongiovanni, Elena Guerini‐Rocco and Anna Ludovica Fracanzani and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Cell Death and Disease.

In The Last Decade

Roberto Piciotti

15 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Piciotti Italy	9	128	92	86	76	50	15	317
Margaret Ottaviano Italy	11	193 1.5×	75 0.8×	153 1.8×	43 0.6×	71 1.4×	62	450
Aslihan Yavas Germany	6	102 0.8×	60 0.7×	75 0.9×	49 0.6×	19 0.4×	11	235
Šárka Svobodová Czechia	13	132 1.0×	42 0.5×	75 0.9×	45 0.6×	61 1.2×	27	299
Jinrui Dong Singapore	7	88 0.7×	68 0.7×	80 0.9×	19 0.3×	84 1.7×	13	311
Elena Trisolini Italy	9	86 0.7×	62 0.7×	55 0.6×	39 0.5×	63 1.3×	13	227
Teruhide Ishigame Japan	12	141 1.1×	43 0.5×	197 2.3×	132 1.7×	101 2.0×	36	406
Takahiko Sakaue Japan	10	101 0.8×	37 0.4×	163 1.9×	102 1.3×	95 1.9×	32	377
Wenfeng Zhang China	12	54 0.4×	61 0.7×	154 1.8×	51 0.7×	38 0.8×	39	313
Brent K. Larson United States	9	157 1.2×	49 0.5×	66 0.8×	75 1.0×	60 1.2×	50	326

Countries citing papers authored by Roberto Piciotti

Since Specialization

Citations

This map shows the geographic impact of Roberto Piciotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Piciotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Piciotti more than expected).

Fields of papers citing papers by Roberto Piciotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Piciotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Piciotti. The network helps show where Roberto Piciotti may publish in the future.

Co-authorship network of co-authors of Roberto Piciotti

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Piciotti. A scholar is included among the top collaborators of Roberto Piciotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Piciotti. Roberto Piciotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Meroni, Marica, et al.. (2024). β-Klotho as novel therapeutic target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A narrative review. Biomedicine & Pharmacotherapy. 180. 117608–117608. 2 indexed citations

Lombardi, Rosa, Roberto Piciotti, Paola Dongiovanni, et al.. (2022). PD-1/PD-L1 Immuno-Mediated Therapy in NAFLD: Advantages and Obstacles in the Treatment of Advanced Disease. International Journal of Molecular Sciences. 23(5). 2707–2707. 22 indexed citations

Meroni, Marica, Erika Paolini, Miriam Longo, et al.. (2022). Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system. Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano). 3 indexed citations

Piciotti, Roberto, Miriam Longo, Erika Paolini, et al.. (2022). Old-fashioned and newly discovered biomarkers: the future of NAFLD-related HCC screening and monitoring. Hepatoma Research. 8. 37–37. 5 indexed citations

Invernizzi, Marco, Konstantinos Venetis, Elham Sajjadi, et al.. (2021). Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients. Current Opinion in Pharmacology. 58. 27–34. 9 indexed citations

Piciotti, Roberto, Konstantinos Venetis, Elham Sajjadi, & Nicola Fusco. (2021). Mismatch Repair Status Characterization in Oncologic Pathology: Taking Stock of the Real-World Possibilities. SHILAP Revista de lepidopterología. 2(2). 93–100. 6 indexed citations

Venetis, Konstantinos, Roberto Piciotti, Elham Sajjadi, et al.. (2021). Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management. Cells. 10(6). 1377–1377. 57 indexed citations

Fusco, Nicola, Moira Ragazzi, Elham Sajjadi, et al.. (2021). Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.. PubMed. 36(12). 1235–1245. 26 indexed citations

Sajjadi, Elham, Konstantinos Venetis, Roberto Piciotti, et al.. (2021). Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling. BMC Cancer. 21(1). 1152–1152. 19 indexed citations

10.

Longo, Miriam, Marica Meroni, Erika Paolini, et al.. (2021). TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models. Cellular and Molecular Gastroenterology and Hepatology. 13(3). 759–788. 82 indexed citations

11.

Blundo, Concetta, Nicola Fusco, Elham Sajjadi, et al.. (2021). Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study. Frontiers in Oncology. 11. 723693–723693. 7 indexed citations

12.

Sajjadi, Elham, Konstantinos Venetis, Roberto Piciotti, et al.. (2021). Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization. Cancer Cell International. 21(1). 266–266. 29 indexed citations

13.

Ghidini, Michele, Angelica Petrillo, Andrea Botticelli, et al.. (2021). How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. Journal of Clinical Medicine. 10(7). 1412–1412. 8 indexed citations

14.

Criscitiello, Carmen, Elena Guerini‐Rocco, Giulia Viale, et al.. (2021). Immunotherapy in Breast Cancer Patients: A Focus on the Use of the CurrentlyAvailable Biomarkers in Oncology. Anti-Cancer Agents in Medicinal Chemistry. 22(4). 787–800. 24 indexed citations

15.

Conti, Filippo, Rita La Rovere, Rik Gijsbers, et al.. (2020). MICAL2 is essential for myogenic lineage commitment. Cell Death and Disease. 11(8). 654–654. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact